DIRECT COMPARISON OF EFFECTIVENESS AND SAFETY OF TOFACITINIB AND BARICITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL-WORLD SETTINGS

被引：0
|
作者：
Iwamoto, N. [1 ]
Suzuki, T. [2 ]
Okada, A. [3 ]
Fujikawa, K. [4 ]
Aramaki, T. [5 ]
Mizokami, A. [4 ]
Ueki, Y. [5 ]
Kawakami, A. [1 ]
机构：
[1] Nagasaki Univ, Grad Sch Biomed Sci, Div Adv Prevent Med Sci, Dept Immunol & Rheumatol, Nagasaki, Japan
[2] Sasebo City Gen Hosp, Dept Internal Med, Sasebo, Japan
[3] Nagasaki Atom Bomb Museum, Dept Rheumatol, Nagasaki, Japan
[4] Japan Community Healthcare Org, Isahaya Gen Hosp, Dept Rheumatol, Isahaya, Japan
[5] Sasebo Chuo Hosp, Dept Rheumatol, Sasebo, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3469
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0674
引用
收藏
页码：581 / 581
页数：1
相关论文
共 50 条
  • [41] The safety of baricitinib in patients with rheumatoid arthritis
    Honda, Suguru
    Harigai, Masayoshi
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (05) : 545 - 551
  • [42] Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
    Blanca Hernández-Cruz
    Uta Kiltz
    Jérôme Avouac
    Tamas Treuer
    Ewa Haladyj
    Jens Gerwien
    Chandreyee Dutta Gupta
    Fabrizio Conti
    Rheumatology and Therapy, 2023, 10 : 1417 - 1457
  • [43] Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis
    Hernandez-Cruz, Blanca
    Kiltz, Uta
    Avouac, Jerome
    Treuer, Tamas
    Haladyj, Ewa
    Gerwien, Jens
    Gupta, Chandreyee Dutta
    Conti, Fabrizio
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1417 - 1457
  • [44] Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
    Martinez-Molina, Cristina
    Diaz-Torne, Cesar
    Park, Hye S.
    Feliu, Anna
    Vidal, Silvia
    Corominas, Hector
    MEDICINA-LITHUANIA, 2024, 60 (03):
  • [45] Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts
    Mueller, Ruediger B.
    Hasler, Caroline
    Popp, Florian
    Mattow, Frederik
    Durmisi, Mirsada
    Souza, Alexander
    Hasler, Paul
    Rubbert-Roth, Andrea
    Schulze-Koops, Hendrik
    von Kempis, Johannes
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
  • [46] Real-world risk factors for herpes zoster in patients with rheumatoid arthritis undergoing tofacitinib treatment
    Sun, Yi-Syuan
    Huang, De-Feng
    Chen, Wei-Sheng
    Liao, Hsien-Tzung
    Chen, Ming-Han
    Tsai, Hung-Cheng
    Tsai, Ming-Tsun
    Tsai, Chang-Youh
    Lai, Chien-Chih
    Yang, Chih-Yu
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2024, 87 (11) : 988 - 992
  • [47] Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis
    Wang, Xin
    Yang, Jing
    Yu, Lan-Yue
    Zhang, Juan
    Zhang, Xu
    Shen, Hai-Li
    CLINICAL RHEUMATOLOGY, 2024, 43 (09) : 2807 - 2815
  • [48] EFFECTIVENESS, TOLERABILITY, AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA FROM THE ST. GALLEN AND AARAU COHORT
    Mueller, R.
    Popp, F.
    Mattowl, F.
    Durmisi, M.
    Souza, A.
    Schulze-Koops, H.
    Hasler, P.
    von Kempis, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1409 - 1409
  • [49] Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study
    Cho, Soo-Kyung
    Song, Yeo-Jin
    Kim, Hye Won
    Nam, Eunwoo
    Jeon, Ja-Young
    Yoo, Hyun-Jeong
    Sung, Yoon-Kyoung
    RHEUMATOLOGY, 2024, 64 (02)
  • [50] TOFACITINIB IN RHEUMATOID ARTHRITIS: AN UPDATED ANALYSIS OF REAL-WORLD DATA IN LATIN AMERICA
    Anzueto, Estuardo
    Maria Rivera, Silvia
    Asnal, Cecilia
    Cruz, Luis Javier
    Caicedo, Tomas
    Felipe, Oscar
    Maria Ventura, Rosa
    del Rosario Maliandi, Maria
    Hadid, Jaime
    Huamanchumo, Roberto
    Ponce de Leon, Dario
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2019, 25 : S50 - S50
12345